Skip to main content

Lasa Supergenerics Ltd

NSE: LASA BSE: 540702

Incorporated in 2016, Lasa Supergenerics Ltd is in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc.[1]

7.8
52W: ₹5.65 — ₹19
PE 145 · Book ₹11.2 · -30% vs book
Market Cap₹39.1 Cr
Stock P/E145Price to Earnings
ROCE1%Return on Capital
ROE1.01%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company has reduced debt.
  • +Stock is trading at 0.67 times its book value

Weaknesses

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -3.16% over past five years.
  • Company has a low return on equity of -9.72% over last 3 years.
  • Company's cost of borrowing seems high

Shareholding Pattern

Promoters53.65%
FIIs0%
DIIs0%
Public46.35%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters53.65%53.65%53.65%53.65%53.65%53.65%53.65%53.65%
FIIs0%0.01%0.00%0.00%0.47%0.50%0.50%0%
DIIs0%0%0%0%0%0%0%0%
Public46.34%46.32%0.046.35%0.046.35%45.88%0.546.35%0.546.34%0.046.35%0.0

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales24.326.6622.8230.8439.3933.0839.1420.013.062.2
Expenses23.2525.626.8129.0438.632.8135.7320.517.062.95
Operating Profit1.051.06-3.991.80.790.273.41-0.5-4-0.75
OPM %4.32%3.98%-17.48%5.84%2.01%0.82%8.71%-2.5%-130.72%-34.09%
Net Profit-0.02-1.46-15.3-2.73-3.235.49-14.29-21.12-6.25-2.55
EPS ₹0-0.29-3.05-0.54-0.641.1-2.85-4.22-1.25-0.51

AI Insights

Revenue Trend

TTM revenue at ₹64Cr, down 54.9% YoY. OPM at -3%.

Debt Position

Borrowings at ₹7Cr. Debt-to-equity ratio: 1.17x. High leverage — monitor closely.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 0% (+0.00pp change). Promoters hold 53.65%.

Margin & Efficiency

ROCE declining from 0% (Mar 2016) to -1% (Mar 2025). Working capital days: 37.

Valuation

PE 145x with 1% ROCE. Price is -30% above book value of ₹11.2. Dividend yield: 0%.

Recent Announcements